Pedal Bcu, Llc
Clinical trials sponsored by Pedal Bcu, Llc, explained in plain language.
-
Promising new combo aims to boost survival in kids with relapsed leukemia
Disease control Recruiting nowThis study tests whether adding the drug venetoclax to standard chemotherapy helps children and young adults with relapsed acute myeloid leukemia (AML) live longer. About 130 participants aged 29 days to 21 years will be randomly assigned to receive either chemotherapy alone or c…
Phase: PHASE3 • Sponsor: PedAL BCU, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for kids with tough leukemia: targeted drug combo enters first human trial
Disease control Recruiting nowThis early-phase trial tests a new drug called ziftomenib, taken as a capsule, together with standard chemotherapy (cytarabine and fludarabine) for children and young adults up to age 21 who have a relapsed or refractory acute leukemia with specific genetic changes (KMT2A-r, NUP9…
Phase: PHASE1 • Sponsor: PedAL BCU, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New screening trial aims to match kids with relapsed leukemia to targeted therapies
Knowledge-focused Recruiting nowThis study screens children and young adults up to age 22 whose leukemia has returned or is hard to treat. By testing their blood and bone marrow, doctors can identify specific genetic markers to match them with the most promising experimental treatments. The goal is to build a r…
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC